Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000933430-19-000001
Filing Date
2019-01-03
Accepted
2019-01-03 11:20:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G clsd13g.txt SC 13G 8205
  Complete submission text file 0000933430-19-000001.txt   9530
Mailing Address 1603 ORRINGTON AVE., STE 900 EVANSTON IL 60201
Business Address
WHITMORE BRADFORD T (Filed by) CIK: 0000933430 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Subject) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89527 | Film No.: 19504032
SIC: 2834 Pharmaceutical Preparations